PURE Bioscience, Inc. reported earnings results for the first quarter ended October 31, 2022. For the first quarter, the company reported revenue was USD 0.471 million compared to USD 0.501 million a year ago. Net loss was USD 0.993 million compared to USD 0.796 million a year ago.

Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.